Distribution of the extracellular matrix glycoproteins in ependymomas - An immunohistochemical study with follow-up analysis

Neoplasma

Volumn 51, Issue 3, 2004, Pages 214-222

  Zamecnik J ^a   Chanova M ^a   Tichy M ^a   Kodet, R ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cartilage; Ependymoma; Extracellular matrix; Prognosis; Tenascin; Vitronectin

Indexed keywords

COLLAGEN TYPE 2; COLLAGEN TYPE 4; COLLAGEN TYPE 6; FIBRONECTIN; GLYCOPROTEIN; LAMININ; SCLEROPROTEIN; TENASCIN; VITRONECTIN;

ADOLESCENT; ARTICLE; BRAIN TUMOR; CARTILAGE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DYSTROPHY; EPENDYMOMA; EXTRACELLULAR MATRIX; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METAPLASIA; NECROSIS; OSSIFICATION; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SURVIVAL;

EID: 3042677674     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. BELLON G, CAULET T, CAM Y, PLUOT M, POULIN G et al. Immunohistochemical localisation of macromolecules of the basement membrane and extracellular matrix of human gliomas and meningiomas. Acta Neuropathol (Berl) 1985; 66: 245-252.
2. BOUFFET E, PERILONGO G, CANETE A, MASSIMINO M. Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation. Med Pediatr Oncol 1998; 30: 319-329.
3. BUCKWALTER JA, MANKIN HJ. Articular cartilage: tissue design and chondrocyte-matrix interactions. Instr Course Lect 1998; 47: 477-486.
4. CHINTALA SK, RAO JK. Invasion of human glioma: Role of extracellular matrix proteins. Front Biosci 1996; 1: 324-339.
5. EYRE D. Collagen of articular cartilage. Arthritis Res 2002; 4: 30-35.
6. FIGARELLA-BRANGER D. CIVATTE M, BOUVIER-LABIT C, GOUVERNET J, GAMBARELLI D et al. Prognostic factors in intracranial ependymomas in children. J Neurosurg 2000; 93: 605-613.
7. FOREMAN NK, LOVE S, THORNE R. Intracranial ependymomas: analysis of prognostic factors in a population-based series. Pediatr Neurosurg 1996; 24: 119-125.
8. FURNESS PN, LOWE J, TARRANT GS. Subepithelial basement membrane deposition and intermediate filament expression in choroid plexus neoplasms and ependymomas. Histopathology 1990; 16: 251-255.
9. GIESE A, WESTPHAL M. Glioma invasion in the central nervous system. Neurosurgery 1996; 39: 235-250.
10. GLADSON CL. The extracellular matrix of gliomas: modulation of cell function. J Neuropathol Exp Neurol 1999; 58: 1029-1040.
11. GLADSON CL, CHERESH DA. Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J Clin Invest 1991; 88: 1924-1932.
12. GLADSON CL, WILCOX JN, SANDERS L, GILLESPIE GY, CHERESH DA. Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors. J Cell Sci 1995; 108: 947-956.
13. GOLDBRUNNER RH, BERNSTEIN JJ, TONN JC. Cell-extracellular matrix interaction in glioma invasion. Acta Neurochir (Wien) 1999; 141: 295-305.
14. HEROLD-MENDE C, MUELLER MM, BONSANTO MM, SCHMITT HP, KUNZE S, STEINER HH. Clinical impact and functional aspects of tenascin-C expression during glioma progression. Int J Cancer 2002; 98: 362-369.
15. HIGUCHI M, OHNISHI T, ARITA N, HIRAGA S, HAYAKAWA T. Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis. Acta Neuropathol (Berl) 1993; 85: 481-487.
16. HO DM, HSU CY, WONG TT, CHIAN H. A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma. J Neurooncol 2001; 54: 77-85.
17. KEPES JJ, RUBINSTEIN LJ, CHIANG H. The role of astrocytes in the formation of cartilage in gliomas. An immunohistochemical study of four cases. Am J Pathol 1984; 117: 471-483.
18. KIM CH, BAK KH, KIM YS, KIM JM, KO Y et al. Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis. Surg Neurol 2000; 54: 235-240.
19. KORSHUNOV A, GOLANOV A, TIMIRGAZ V. Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases. J Neurol Sci 2000; 177: 72-82.
20. MAHESPARAN R, READ TA, LUND-JOHANSEN M, SKAFTNESMO KO, BJERKVIG R, ENGEBRAATEN O. Expression of extracellular matrix components in a highly infiltrative in vivo glioma model. Acta Neuropathol (Berl) 2003; 105: 49-57.
21. MATHEWS T, MOOSSY J. Gliomas containing bone and cartilage. J Neuropathol Exp Neurol 1974; 33: 456-471.
22. MCCOMB RD, BIGNER DD. Immunolocalization of laminin in neoplasms of the central and peripheral nervous systems. J Neuropathol Exp Neurol 1985; 44: 242-253.
23. MCCOMB RD, MOUL JM, BIGNER DD. Distribution of type VI collagen in human gliomas: comparison with fibronectin and glioma-mesenchymal matrix glycoprotein. J Neuropathol Exp Neurol 1987; 46: 623-633.
24. NOVAK U, KAYE AH. Extracellular matrix and the brain: components and function. J Clin Neurosci 2000; 7: 280-290.
25. OHNISHI T, HIRAGA S, IZUMOTO S, MATSUMURA H, KANEMURA Y et al. Role of fibronectin-stimulated tumor cell migration in glioma invasion in vivo: clinical significance of fibronectin and fibronectin receptor expressed in human glioma tissues. Clin Exp Metastasis 1998; 16: 729-741.
26. OZ B, KARAYEL FA, GAZIO NL, OZLEN F, BALCI K. The distribution of extracellular matrix proteins and CD44S expression in human astrocytomas. Pathol Oncol Res 2000; 6: 118-124.
27. PAULUS W. Brain extracellular matrix, adhesion molecules and glioma invasion. In: Mikkelsen T, Bjerkvig R, Laerum OD, Rosenblum ML, editors. Brain Tumor Invasion: Biological, Clinical and Therapeutic Considerations. New York, Wiley-Liss, 1998, 301-322.
28. PAULUS W, HUETTNER C, TONN JC. Collagens, integrins and the mesenchymal drift in glioblastomas: a comparison of biopsy specimens, spheroid and early monolayer cultures. Int J Cancer 1994; 58: 841-846.
29. PRAYSON RA. Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry. Ann Diagn Pathol 1999; 3: 11-18.
30. ROBERTSON PL, ZELTZER PM, BOYETT JM, RORKE LB, ALLEN JC et al. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J Neurosurg 1998; 88: 695-703.
31. ROSS GW, RUBINSTEIN LJ. Lack of histopathological correlation of malignant ependymomas with postoperative survival. J Neurosurg 1989; 70: 31-36.
32. SIQUEIRA EB, BUCY PC, Case report. Chondroma arising within a mixed glioma. J Neuropathol Exp Neurol 1966; 25: 667-673.
33. SOEUR M, MONSEU G, KETALBANT P, FLAMENT-DURAND J. Intramedullary ependymoma producing collagen. A clinical and pathological study. Acta Neuropathol (Berl) 1979; 47: 159-160.
34. SUZUKI S, OKA H, KAWANO N, TANAKA S, UTSUKI S, FUJII K. Prognostic value of Ki-67 (MIB-1) and p53 in ependymomas. Brain Tumor Pathol 2001; 18: 151-154.
35. TYSNES BB, MAHESPARAN R, THORSEN F, HAUGLAND HK, PORWOL T et al. Laminin expression by glial fibrillary acidic protein positive cells in human gliomas. Int J Dev Neurosci 1999; 17: 531-539.
36. TAKAHASHI H, GOTO J. EMURA I, HONMA T, HASEGAWA K, UCHIYAMA S. Lipidized (foamy) tumor cells in a spinal cord ependymoma with collagenous metaplasia. Acta Neuropathol 1998; 95: 421-425.
37. VEGE KD, GIANNINI C, SCHEITHAUER BW. The immunophenotype of ependymomas. Appl Immunohistochem Mol Morphol 2000; 8: 25-31.
38. VEJE K, HYLLESTED-WINGE JL, OSTERGAARD K. Topographic and zonal distribution of tenascin in human articular cartilage from femoral heads: normal versus mild and severe osteoarthritis. Osteoarthritis Cartilage 2003; 11: 217-227.
39. WIESTLER DO, SCHIFFER D, COONS SW, PRAYSON R A, ROSENBLUM MK. Ependymoma. Anaplastic ependymoma. In: Kleihues P, Cavenee WK, editors. WHO Classification of Tumours: Pathology and Genetics of Tumours of the Nervous System. Lyon, IARC Press, 2000, 72-77.
40. ZAMECNIK J, SNUDERL M. ECKSCHLAGER T, CHANOVA M, TICHY M, KODET R. Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical and flow cytometric factors. Mod Pathol 2003; 16: 980-991.